MedTrace Logo

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion

NCT01108562 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2015-04-06

No results posted yet for this study

Summary

This study will focus on patients undergoing total hip arthroplasty and Loma Linda University Medical Center \& East Campus. These patients will be randomized to receive a low dose lidocaine infusion or placebo, in addition to the patient controlled analgesia pump. These groups will be compared to one another statistically to determine which group shows the safest and most satisfying pain control.

Conditions

  • Postoperative Pain Management After Total Hip Arthroplasty

Interventions

DRUG

Lidocaine

Patients in the experimental group will be receiving a Lidocaine infusion at 1.33 mg/kg/hr for 24 hours postoperatively.

OTHER

Normal Saline

Patients in the control group will be receiving an infusion of normal saline for 24 hours postoperatively.

Sponsors & Collaborators

  • Charles Lee MD

    collaborator UNKNOWN

  • Michelle Schlunt MD

    collaborator UNKNOWN

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Michelle L Schlunt, MD · Loma Linda University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108562 on ClinicalTrials.gov